CALML5 Polyclonal antibody
CALML5 Polyclonal Antibody for IHC, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human
Applications
IHC, ELISA and More (1)
Conjugate
Unconjugated
验证数据展示
经过测试的应用
Positive IHC detected in | human skin cancer tissue, human breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
推荐稀释比
Application | Dilution |
---|---|
Immunohistochemistry (IHC) | IHC : 1:300-1:1200 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
IHC | See 2 publications below |
IF | See 1 publications below |
产品信息
13059-1-AP targets CALML5 in IF, IHC, ELISA applications and shows reactivity with human samples.
Tested Applications | IHC, ELISA Application Description |
Cited Applications | IF, IHC |
Tested Reactivity | human |
Cited Reactivity | human |
Immunogen | CALML5 fusion protein Ag3734 种属同源性预测 |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Full Name | calmodulin-like 5 |
Synonyms | CALML5, calmodulin like 5, Calmodulin like protein 5, Calmodulin like skin protein, CLSP |
Calculated Molecular Weight | 146 aa, 16 kDa |
GenBank Accession Number | BC039172 |
Gene Symbol | CALML5 |
Gene ID (NCBI) | 51806 |
RRID | AB_2069463 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
UNIPROT ID | Q9NZT1 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
实验方案
Product Specific Protocols | |
---|---|
IHC protocol for CALML5 antibody 13059-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Ann Diagn Pathol Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia. | ||
Elife Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer |